药物性肝损伤的长期后遗症
药物性肝损伤(DILI)临床和生化表型差异大,严重程度从轻微损伤到危及生命的肝衰竭不等。停用可疑药物后6-12个月,慢性损伤发生率为3.4%至39%,范围宽可能与慢性肝损伤定义和患者选择不同有关。慢性损伤的长期后遗症在发病率和死亡率方面尚不明确,但罕见的胆管消失综合征预后不良,与慢性肝衰竭风险增加和需要肝移植相关。
要点
- 停用可疑药物后6-12个月慢性损伤发生率为3.4%至39%
- 罕见胆管消失综合征预后不良,增加慢性肝衰竭和肝移植风险
- 免疫检查点抑制剂可致胆管CD8+ T细胞浸润的硬化性胆管炎
核心结论
- DILI慢性损伤发生率为3.4%至39%,长期后遗症包括进展性纤维化、自身免疫样肝炎、继发性硬化性胆管炎、肝窦阻塞综合征及肝硬化门脉高压等。
- DILI对健康相关生活质量有显著影响,但长期心理后果知之甚少。
研究设计与样本
- 本文为综述,总结DILI长期后遗症的文献证据。
主要发现
- 停用可疑药物后6-12个月慢性损伤发生率为3.4%至39%。
- 罕见胆管消失综合征预后不良,慢性肝衰竭风险增加且需要肝移植。
- 长期后遗症还包括进展性纤维化、自身免疫样肝炎、继发性硬化性胆管炎、肝窦阻塞综合征,最终可发展为肝硬化、门脉高压及其并发症。
- 免疫检查点抑制剂可导致自身免疫样表型,近期显示可引起胆管细胞毒性T CD8+细胞浸润的硬化性胆管炎。
- DILI对健康相关生活质量有显著影响,但长期心理后果所知甚少。
临床怎么用
- 对DILI患者应进行结构化长期随访,关注慢性损伤及后遗症。
- 需定期评估生活质量,尤其对存在慢性后遗症者。
局限性
- 慢性损伤发生率范围宽,可能与慢性肝损伤定义和患者选择不同有关。
- 慢性损伤的长期后遗症在发病率和死亡率方面尚不明确。
- DILI长期心理后果研究很少,需进一步调查。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Drug-induced liver injury (DILI) has a very variable clinical and biochemical phenotype and differs widely in severity, from mild injury to life-threatening liver failure. Chronic injury has also been reported to occur at a variable frequency, ranging from 3.4% to 39%, 6-12 months after discontinuing the implicated agent. This wide range is probably related to various definitions of chronic liver injury and variable selection of patients. The long-term sequalae of this chronic injury in terms of morbidity and mortality are unclear, although rare vanishing bile duct syndrome is associated with an unfavourable prognosis, with increased risk of chronic liver failure and need for liver transplantation. Other forms of long-term sequalae associated with DILI are progressive fibrosis, autoimmune-like hepatitis, secondary sclerosing cholangitis, sinusoidal obstruction syndrome and, as a common final stage, the development of cirrhosis, portal hypertension and its complications. Immune checkpoint inhibitors, which can cause an autoimmune-like phenotype have also recently been shown to cause sclerosing cholangitis with cytotoxic T CD8+ cell infiltration in biliary tracts. DILI has been shown to have a significant impact on health-related quality of life but very little is known about its psychological consequences in the long-term. Further investigations with structured long-term follow-up and periodic quality of life surveys are needed to assess the impact of DILI on psychological outcomes, particularly in those with chronic sequelae.
引用
- Björnsson ES, Andrade RJ. Long-term sequelae of drug-induced liver injury. J Hepatol. 2021. PMID: 34688732. doi:10.1016/j.jhep.2021.10.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。